# Federal National Mortgage Association Fannie Mae: financial statements, quarterly

FNMA · OTC · CIK 310522 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnma.md) · [Financials](/companies/fnma/financials.md) · [Filings](/companies/fnma/filings.md) · [Insiders](/companies/fnma/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnma/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [7.8 d](/filings/0000310522-26-000015.md) | [7.1](/filings/0000310522-25-000235.md) | [7.3](/filings/0000310522-25-000466.md) | [7.3](/filings/0000310522-25-000512.md) | [7.3 d](/filings/0000310522-26-000015.md) | [7.1](/filings/0000310522-26-000040.md) | [7.2](/filings/0000310522-26-000064.md) | [7.3](/filings/0000310522-26-000089.md) | [7.3 d](/filings/0000310522-26-000015.md) | [7.3](/filings/0000310522-26-000040.md) | [7.6](/filings/0000310522-26-000064.md) | [7.7](/filings/0000310522-26-000089.md) |
| Selling, general and administrative | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $bn | [28.7 d](/filings/0000310522-24-000184.md) | [29.8](/filings/0000310522-24-000239.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [1.0 d](/filings/0000310522-26-000015.md) | [1.1](/filings/0000310522-25-000235.md) | [1.1](/filings/0000310522-25-000466.md) | [1.0](/filings/0000310522-25-000512.md) | [1.0 d](/filings/0000310522-26-000015.md) | [0.9](/filings/0000310522-26-000040.md) | [0.8](/filings/0000310522-26-000064.md) | [1.0](/filings/0000310522-26-000089.md) | [0.9 d](/filings/0000310522-26-000015.md) | [0.9](/filings/0000310522-26-000040.md) | [1.0](/filings/0000310522-26-000064.md) | [0.9](/filings/0000310522-26-000089.md) |
| Net income | $bn | [3.9 d](/filings/0000310522-26-000015.md) | [4.3](/filings/0000310522-25-000235.md) | [4.5](/filings/0000310522-25-000466.md) | [4.0](/filings/0000310522-25-000512.md) | [4.1 d](/filings/0000310522-26-000015.md) | [3.7](/filings/0000310522-26-000040.md) | [3.3](/filings/0000310522-26-000064.md) | [3.9](/filings/0000310522-26-000089.md) | [3.5 d](/filings/0000310522-26-000015.md) | [3.7](/filings/0000310522-26-000040.md) | [4.0](/filings/0000310522-26-000064.md) | [4.2](/filings/0000310522-26-000089.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0000310522-25-000235.md) | [0.00](/filings/0000310522-25-000466.md) | [0.00](/filings/0000310522-25-000512.md) | not reported | [0.00](/filings/0000310522-26-000040.md) | [0.00](/filings/0000310522-26-000064.md) | [0.00](/filings/0000310522-26-000089.md) | not reported | [0.01](/filings/0000310522-26-000040.md) | [0.03](/filings/0000310522-26-000064.md) | [0.18](/filings/0000310522-26-000089.md) |
| Basic EPS | $ per share | not reported | [0.00](/filings/0000310522-25-000235.md) | [0.00](/filings/0000310522-25-000466.md) | [0.00](/filings/0000310522-25-000512.md) | not reported | [0.00](/filings/0000310522-26-000040.md) | [0.00](/filings/0000310522-26-000064.md) | [0.00](/filings/0000310522-26-000089.md) | not reported | [0.01](/filings/0000310522-26-000040.md) | [0.03](/filings/0000310522-26-000064.md) | [0.18](/filings/0000310522-26-000089.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Selling, general and administrative: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [35.8](/filings/0000310522-25-000199.md) | [12.5](/filings/0000310522-24-000239.md) | [41.9](/filings/0000310522-24-000442.md) | [38.1](/filings/0000310522-24-000632.md) | [38.9](/filings/0000310522-25-000466.md) | [39.4](/filings/0000310522-25-000235.md) | [38.2](/filings/0000310522-25-000466.md) | [12.2](/filings/0000310522-25-000512.md) | [11.5](/filings/0000310522-26-000089.md) | [11.5](/filings/0000310522-26-000040.md) | [11.4](/filings/0000310522-26-000064.md) | [10.9](/filings/0000310522-26-000089.md) |
| Total assets | $bn | [4,325](/filings/0000310522-25-000199.md) | [4,324](/filings/0000310522-24-000239.md) | [4,324](/filings/0000310522-24-000442.md) | [4,335](/filings/0000310522-24-000632.md) | [4,350](/filings/0000310522-26-000015.md) | [4,354](/filings/0000310522-25-000235.md) | [4,338](/filings/0000310522-25-000466.md) | [4,336](/filings/0000310522-25-000512.md) | [4,318](/filings/0000310522-26-000089.md) | [4,315](/filings/0000310522-26-000040.md) | [4,332](/filings/0000310522-26-000064.md) | [4,318](/filings/0000310522-26-000089.md) |
| Total liabilities | $bn | [4,248](/filings/0000310522-25-000199.md) | [4,242](/filings/0000310522-24-000239.md) | [4,237](/filings/0000310522-24-000442.md) | [4,244](/filings/0000310522-24-000632.md) | [4,255](/filings/0000310522-26-000015.md) | [4,255](/filings/0000310522-25-000235.md) | [4,237](/filings/0000310522-25-000466.md) | [4,230](/filings/0000310522-25-000512.md) | [4,209](/filings/0000310522-26-000089.md) | [4,202](/filings/0000310522-26-000040.md) | [4,216](/filings/0000310522-26-000064.md) | [4,198](/filings/0000310522-26-000089.md) |
| Long-term debt | $bn | [4,205](/filings/0000310522-25-000199.md) | [4,202](/filings/0000310522-24-000239.md) | [4,201](/filings/0000310522-24-000442.md) | [4,206](/filings/0000310522-24-000632.md) | [4,217](/filings/0000310522-26-000015.md) | [4,218](/filings/0000310522-25-000235.md) | [4,199](/filings/0000310522-25-000466.md) | [4,183](/filings/0000310522-25-000512.md) | [4,156](/filings/0000310522-26-000089.md) | [4,152](/filings/0000310522-26-000040.md) | [4,161](/filings/0000310522-26-000064.md) | [4,138](/filings/0000310522-26-000089.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [77.7](/filings/0000310522-25-000199.md) | [82.0](/filings/0000310522-24-000239.md) | [86.5](/filings/0000310522-24-000442.md) | [90.5](/filings/0000310522-24-000632.md) | [94.7](/filings/0000310522-26-000015.md) | [98.3](/filings/0000310522-25-000235.md) | [102](/filings/0000310522-25-000466.md) | [105](/filings/0000310522-25-000512.md) | [109](/filings/0000310522-26-000089.md) | [113](/filings/0000310522-26-000040.md) | [116](/filings/0000310522-26-000064.md) | [120](/filings/0000310522-26-000089.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [2.0 d](/filings/0000310522-26-000015.md) | [7.1](/filings/0000310522-25-000235.md) | [1.5 d](/filings/0000310522-25-000466.md) | [(6.8) d](/filings/0000310522-25-000512.md) | [(12.4) d](/filings/0000310522-26-000015.md) | [3.5](/filings/0000310522-26-000040.md) | [4.9 d](/filings/0000310522-26-000064.md) | [9.6 d](/filings/0000310522-26-000089.md) | [6.0 d](/filings/0000310522-26-000015.md) | [16.5](/filings/0000310522-26-000040.md) | [9.3 d](/filings/0000310522-26-000064.md) | [0.9 d](/filings/0000310522-26-000089.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5,867](/filings/0000310522-24-000239.md) | [5,867](/filings/0000310522-24-000442.md) | [5,893](/filings/0000310522-24-000632.md) | [5,867](/filings/0000310522-25-000235.md) | [5,893](/filings/0000310522-25-000466.md) | [5,867](/filings/0000310522-25-000512.md) | [5,893](/filings/0000310522-26-000040.md) | [5,867](/filings/0000310522-26-000064.md) | [5,893](/filings/0000310522-26-000089.md) | [5,893](/filings/0000310522-26-000040.md) | [5,893](/filings/0000310522-26-000064.md) | [5,893](/filings/0000310522-26-000089.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,158,087,567 at 2026-10-09, from the cover of the [10-Q filed 2026-10-28](/filings/0000310522-26-000089.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 28, 2026, 08:25 ET. No prices; not investment advice.